Evidence map›Paper›PMID 41179539›Full record

ReviewAfrican health sciences2025

Effects of Genetic polymorphism in susceptibility to schistosomiasis infection and adverse treatment outcomes.

Akingbolabo Daniel Ogunlakin, Oluwafemi Adeleke Ojo, Oluwaseun Abigael Ogunlakin, Ajibola David Adelakun, Ayobami Tosin Adegbenro, Favour Inijesunimi Olagookun, Sophie Adedamola Adeyeye, Mubo Adeola Sonibare

Abstract readReview
In one paragraph

Review in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Akingbolabo Daniel OgunlakinBowen University SDG 03 (Good Health and Wellbeing Research Cluster), Iwo, Nigeria.
Oluwafemi Adeleke OjoBowen University SDG 03 (Good Health and Wellbeing Research Cluster), Iwo, Nigeria.
Oluwaseun Abigael OgunlakinAgricultural sciences programme, Bowen University, Iwo, 232101, Nigeria.
Ajibola David AdelakunDepartment of Pharmaceutical Sciences, University of Arizona, Arizona, USA.
Ayobami Tosin AdegbenroDepartment of Biochemistry and Molecular Biology, Obafemi Awolowo University, Ile-Ife, Nigeria.
Favour Inijesunimi OlagookunDepartment of Biochemistry and Molecular Biology, Obafemi Awolowo University, Ile-Ife, Nigeria.
Sophie Adedamola AdeyeyeDepartment of Plant Science, Olabisi Onabanjo University, Ago-Iwoye, Ogun State, Nigeria.
Mubo Adeola SonibareDepartment of Pharmacognosy, University of Ibadan, Ibadan. Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis is a serious tropical disease that is undiagnosed (Neglected tropical disease -NTD). The only disease with a more detrimental socio-economic impact than its causative agent is malaria. Over 250 million individuals are presently afflicted with Schistosomiasis haematobium, and an additional 779 million people are at risk of infection in regions where the disease is endemic. Africa is home to many incidences, which account for roughly 90% of infections. Every year in underdeveloped nations, schistosomiasis claims the lives of 11,700 people and disables over 3.3 million others. The parasite is still dangerous everywhere in the world, even in non-endemic places. This review delves deeply into genetic polymorphism and its different forms. It also addresses genetic polymorphism to susceptibility. It has been found that environmental factors are among the many variables that influence susceptibility to schistosomiasis. Schistosomiasis susceptibility is influenced by age, gender, and even pathological infections. The primary locus SM1, situated on chromosome 5q31-q33, regulates the extent of S. mansoni and S. haematobium infection by including multiple genes associated with the Th2 immune response. The chromosome 5q31-q33 Th2 cluster gene, which regulates the synthesis of interleukin 13, interleukin 4, and interleukin 5, is primarily linked to an increased risk of developing schistosomiasis.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticSchistosomiasisAnimalsHumansSchistosoma haematobiumChromosomeGenetic polymorphismPrimary locusSchistosomiasisTropical disease

Identifiers

PMID41179539
PMCPMC12573647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.